Kurtoglu Metin's Form 4 filing
Cartesian Therapeutics, Inc. (RNAC) · filed Jan 7, 2025
- Accession no.
- 0001453687-25-000040
- Filed
- Jan 7, 2025
- Trade date
- Jan 3-6, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $81.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kurtoglu MetinCIK 0002000284 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Common Stock | SSaleDisposed | −2,417 | $16.72 | −$40,412.24 | 64,716 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −2,458 | $16.83 | −$41,368.14 | 62,258 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.